Vital Signs - Human Growth Hormone - A Multifaceted Paradigm for Specialty Pharma
Vital Signs - Human Growth Hormone - A Multifaceted Paradigm for Specialty Pharma
RELEASE DATE
01-Oct-2007
01-Oct-2007
REGION
North America
North America
Research Code: 9561-00-44-00-00
SKU: HC00500-NA-MR_03972
$1,500.00
In stock
SKU
HC00500-NA-MR_03972
Description
This issue of Vital Signs, released on October 1, 2007, provides a strategic overview of issues and opportunities surrounding human growth hormone. Additionally, a company spotlight is provided for BioMS Medical, a biotechnology company with a core interest in the treatment of multiple sclerosis. Reimbursement and regulatory news from the FDA is also provided for the week of September 17 - September 21, 2007.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on October 1, 2007, provides a strategic overview of issues and opportunities surrounding human growth hormone. Additionally, a company spotlight is provided for BioMS Medical, a biotechnology company with a core interest in the treatment of multiple sclerosis. Reimbursement and regulatory news from the FDA is also provided for the week of September 17 - September 21, 2007.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-44-00-00 |
Is Prebook | No |